Basic fibroblast growth factor (bFGF) is a potent neurotrophic factor that regulates cell proliferation and differentiation during neuronal development. Here we report that fetal hippocampal neurons chronically treated with bFGF displayed larger [Ca 2ϩ ] i increases than nontreated neurons in response to high K currents remained unchanged. bFGF-stimulated increase in Ca 2ϩ response was not observed in neurons treated with cycloheximide or actinomycin D, indicating that protein and RNA synthesis were required for this effect. Visualization using a fluorescent dihydropyridine analog revealed that bFGF-treated neurons expressed increased amounts of L-type Ca 2ϩ channels on the cell body. In addition, bFGF-treated neurons acquired distinctive morphology of neurites that was characterized by markedly increased neuritic branching. The branching points in neurites were associated with clusters of L-type Ca 2ϩ channels and resultant "Ca 2ϩ hotspots" that showed large [Ca 2ϩ ] i increases in response to membrane depolarization. Concurrent application of nicardipine completely blocked the bFGF-stimulated increase in neuritic branching. Therefore, bFGF enhances the expression of functional L-type Ca 2ϩ channels on the cell body and neurites of fetal hippocampal neurons, which may play an important role in the regulation of their differentiation and the establishment of their neurite morphology.
Basic fibroblast growth factor (bFGF) is a potent neurotrophic factor that regulates cell proliferation and differentiation during neuronal development. Here we report that fetal hippocampal neurons chronically treated with bFGF displayed larger [Ca 2ϩ ] i increases than nontreated neurons in response to high K ϩ -induced depolarization. This [Ca 2ϩ ] i response was abolished by nicardipine and was little affected by treatments that depleted intracellular Ca 2ϩ stores, thus reflecting the activities of L-type voltage-dependent Ca 2ϩ channels. Whole-cell recordings also demonstrated increased high-voltage-activated Ca 2ϩ currents in bFGF-treated neurons, whereas low-voltage-activated Ca 2ϩ currents remained unchanged. bFGF-stimulated increase in Ca 2ϩ response was not observed in neurons treated with cycloheximide or actinomycin D, indicating that protein and RNA synthesis were required for this effect. Visualization using a fluorescent dihydropyridine analog revealed that bFGF-treated neurons expressed increased amounts of L-type Ca 2ϩ channels on the cell body. In addition, bFGF-treated neurons acquired distinctive morphology of neurites that was characterized by markedly increased neuritic branching. The branching points in neurites were associated with clusters of L-type Ca 2ϩ channels and resultant "Ca 2ϩ hotspots" that showed large [Ca 2ϩ ] i increases in response to membrane depolarization. Concurrent application of nicardipine completely blocked the bFGF-stimulated increase in neuritic branching. Therefore, bFGF enhances the expression of functional L-type Ca 2ϩ channels on the cell body and neurites of fetal hippocampal neurons, which may play an important role in the regulation of their differentiation and the establishment of their neurite morphology.
Key words: basic fibroblast growth factor; hippocampal neurons; neuronal development; calcium; channel; expression; channel distribution; neurite branching Neuronal development proceeds through several steps of sequential processes, including proliferation of neural precursor cells, their migration, and their differentiation into mature neurons with specialized morphological and functional characteristics. These processes are under strong influences of various cellular interactions that are mediated by cell-surface molecules and diffusible trophic factors.
Basic fibroblast growth factor (bFGF) is a single-chain polypeptide composed of 146 amino acids and is well known as a potent mitogen for various cell types. High levels of bFGF and its receptors are found during nervous system development (Gonzalez et al., 1990; Wanaka et al., 1991) , and bFGF stimulates proliferation of neuronal progenitor cells (Gensburger et al., 1987; Vescovi et al., 1993; DeHamer et al., 1994) . In addition to its mitogenic effect, bFGF acts as a neurotrophic factor based on its ability to support the survival of neurons of various brain regions (Morrison et al., 1986; Walicke et al., 1986; Ferrari et al., 1989; Matsuda et al., 1990) and to promote neuronal differentiation (Ray et al., 1993; Vicario-Abejon et al., 1995) , including the establishment of neurite morphology (Hatten et al., 1988; Aoyagi et al., 1994) ; however, much is unknown concerning the precise mechanisms by which bFGF exerts these multiple and potent effects on neuronal cells.
Changes in the expression patterns of ion channels are likely to be an important feature of neuronal development. Developmental changes in neuronal electrical excitability, which is determined by ion channel expression, are also considered to be regulated by many kinds of environmental factors such as direct interactions with other cell types (Wu and Barish, 1994) and neurotrophic factors (Dourado and Dryer, 1994) . Voltage-dependent Ca 2ϩ channels (VDCCs), the major pathways for Ca 2ϩ influx across the plasma membrane, are the first of the voltage-activated ion channels to be detected during development of various neurons (Spitzer, 1979) , and they undergo progressive changes in their expression or localization (Yaari et al., 1987; McCobb et al., 1989; Gottmann et al., 1991; Thompson and Wong, 1991; Gruol et al., 1992; Desarmenien et al., 1993) . Ca 2ϩ is an important intracellular messenger known to control many aspects of neuronal functions such as enzyme activity, gene expression, synaptic function, and neurotransmitter release. Ca 2ϩ influx during developmental stages can influence neuronal differentiation processes (Spitzer, 1994) including neurite outgrowth (Cohan et al., 1987; Mattson and Kater, 1987) and cell survival (Collins and Lile, 1989; Ghosh et al., 1994) . Therefore, changes in Ca 2ϩ channel expression could profoundly affect elaboration of neuronal phenotypes in the developing nervous system.
Because of the particular importance of Ca 2ϩ in neuronal development, we were interested in the possible roles of bFGF in the regulation of Ca 2ϩ channel expression. Here we provide evidence that bFGF enhances the expression of L-type VDCCs in cultured fetal hippocampal neurons, which is closely associated with its morphogenic effect on the neurites of these neurons.
MATERIALS AND METHODS
Culture medium. Modified Eagle's medium is composed of 8.73 mg/ml Eagle's minimal essential medium powder (Nissui Pharmaceuticals, Tokyo, Japan) supplemented with 8.2 mg/ml D-glucose, 0.29 mg/ml L-glutamine, 1.7 mg/ml NaHCO 3 , and 94 g/ml sodium pyruvate. Where indicated, 10% (v/v) heat-inactivated fetal bovine serum (FBS) (SankoJunyaku, Tokyo, Japan) was added. Human transferrin (100 g/ml) (Sigma, St. Louis, MO), bovine insulin (5 g/ml, Becton Dickinson, Bedford, MA), progesterone (20 nM, Sigma), and putrescine (100 M, Sigma) were added to the medium for serum-free culture. We found that in this serum-free condition nicardipine showed cytotoxicity, decreasing the number of surviving neurons when added chronically to the culture medium. Therefore, in the experiments presented in Figure 8 we used B-27 supplement (Life Technologies, Gaithersburg, MD), which was found to eliminate the cytotoxicity of nicardipine. The effects of bFGF on Ca 2ϩ responses and neurite morphogenesis were similarly observed in the presence of either supplement.
Cell culture. The culture of dissociated hippocampal neurons was prepared according to the methods described previously (Okuda et al., 1994) , with some modifications. Plastic 35 mm dishes (Becton Dickinson) and 15-mm-round glass coverslips (Matsunami, Osaka, Japan) were treated with 0.1% polyethyleneimine (Sigma) dissolved in 0.15 M borate buffer, pH 8.4. The coverslips were cleaned and sterilized in 70% ethanol before they were coated. They were then rinsed twice with sterile distilled water. Whole brains were isolated from embryonic day 18 Wistar rats (SLC, Shizuoka, Japan), and the hippocampi were further dissected out. The tissue was cut into pieces with knives and incubated with 0.25% trypsin (1:250, Difco, Detroit, MI) and 0.01% deoxyribonuclease I (Sigma) at 37ЊC for 15 min. The incubation was terminated by the addition of heat-inactivated horse serum (Cell Culture Lab, Cleveland, OH). The tissue fragments were centrifuged at 1200 rpm for 5 min. The pellets were suspended again in modified Eagle's medium containing 10% FBS, and single cells were dissociated by gently passing the suspension through a plastic tip. The cell suspension was passed through two sheets of nylon net (25 m mesh) to remove cell lumps and was diluted with the medium containing 10% FBS. The suspension was plated on 15-mm-round glass coverslips to obtain a final density of 2.5 ϫ 10 4 cells/cm 2 for the experiments on the [Ca 2ϩ ] i measurement and the binding of (Ϫ)-(4,4-difluoro-7-styryl-4-bora-3a,4a-diaza)-3-(s-indacene)propionic acid-labeled dihydropyridine (STBodipy-DHP, Molecular Probes, Eugene, OR), and 2.5 ϫ 10 3 cells/cm 2 for the experiments on the neurite morphology. For wholecell recording experiments, the suspension was plated on 35 mm plastic dishes to obtain a final density of 1 ϫ 10 4 cells/cm 2 . They were cultured at 37ЊC in a humidified 5% CO 2 /95% air atmosphere. To prevent proliferation of glial cells, the FBS-containing medium was changed to the serum-free medium within 12 hr (0.5 d) after plating the cells. bFGF was added to the cultures at 0.5 or 2 d in vitro (DIV) . When added at 0.5 DIV, bFGF was supplemented again at 2 DIV. When the effects of actinomycin D (Sigma), cycloheximide, nicardipine or -conotoxin GVIA (-CTx, Alomone Labs, Jerusalem, Israel) on the action of bFGF were examined, each drug was added to cultures 30 min before the application of bFGF. Ca 2ϩ imaging. Changes in [Ca 2ϩ ] i at somatic regions were detected by a standard microfluorometrical technique using fura-2, according to the methods described previously (Tanaka et al., 1993) . Briefly, the cultured cells at 4 DIV (unless indicated otherwise) were incubated in a medium containing 10 M fura-2 acetoxymethyl ester at 37ЊC for 60 min. The cells then were rinsed with HEPES-buffered balanced salt solution (BSS) of the following composition (in mM): 130 NaCl, 5 KCl, 1.8 CaCl 2 , 10 D-glucose, and 20 HEPES, pH 7.4 with NaOH. The coverslip with the fura-2-loaded cells was mounted on the stage of an inverted microscope (Nikon, Tokyo, Japan). The cultures then were perfused continuously with BSS at a rate of 3.5 ml/min (chamber volume 0.3 ml) throughout the experiments. An image analysis system FC-200 (Mitsubishi Kasei, Tokyo, Japan) was used to monitor the ratio of the intensity of fura-2 fluorescence excited at 340 nm and 360 nm. For calibration of free Ca 2ϩ concentrations, 10 M fura-2 was suspended in standard solutions of 50 mM PIPES-KOH buffer, pH 6.8, containing EGTA and CaCl 2 at calculated ratios (Harafuji and Ogawa, 1980) , and illuminated by 340 nm and 360 nm beams alternately in vitro (Kudo and Ogura, 1986) . Intracellular Ca 2ϩ responses were quantified by peak amplitudes. Baseline Ca 2ϩ levels were subtracted from the peak amplitude values in individual cells.
To test voltage-dependent Ca 2ϩ responses, the cells were depolarized with 50 mM KCl solution (KCl was substituted for equimolar NaCl in BSS) for 15 sec, which was applied from a rapid perfusion system consisting of an array of 280 m inner diameter capillary tubes positioned within 200 m from the cells under study. The solution was fed by gravity (ϳ300 l/min). Other drugs applied acutely were also perfused through the same capillary tubes. For experiments involving VDCC blockers, 50 mM K ϩ solution was applied repeatedly at 10 -12 min intervals, and each blocker was applied 3-6 min before the second application of 50 mM K ϩ . We noted that the amplitude of Ca 2ϩ responses was consistent among neurons from the same sister cultures, but it varied considerably among those from different sister cultures. Therefore, in all sets of experiments, the effects of drug treatments were evaluated by comparison of responses of neurons obtained from the same sister cultures.
For the experiments on [Ca 2ϩ ] i responses in neurites, the cultured cells were incubated in a medium containing 10 M fluo-3 acetoxymethyl ester and 0.05% Pluronic F127 at 37ЊC for 60 min. Other procedures followed those in the experiments with fura-2 described above, except for the use of devices with a confocal laser microscope (see below). All experiments were performed at room temperature (23-27ЊC).
Whole-cell recording. Whole-cell voltage-clamp recordings were made from the hippocampal neurons with neurites at 4 DIV, unless indicated otherwise. A culture dish was settled on the stage of an inverted microscope (Olympus, Tokyo, Japan) and was perfused at 3.5 ml/min with an extracellular solution of the following composition (in mM): 110 choline chloride, 30 tetraethylammonium chloride (Sigma), 10 HEPES, 10 D-glucose, 1 MgCl 2 , 10 CaCl 2 , and 0.05% bovine serum albumin (Sigma), pH adjusted to 7.3 with tetraethylammonium hydroxide (Sigma). The recording patch pipette (3-5 M⍀) was filled with the intracellular solution of the following composition (in mM): 120 CsCl, 20 tetraethylammonium chloride, 10 HEPES, 10 EGTA, 2 MgCl 2 , and 3 Mg-ATP, pH adjusted to 7.3 with CsOH. An array of capillary tubes was positioned within 300 m from the cell under study, and the extracellular solution containing 1 M tetrodotoxin (Sigma) and 5 mM 4-aminopyridine was perfused continuously (ϳ300 l/min). Membrane currents were recorded under voltage-clamp conditions using a patch-clamp amplifier CEZ-2300 (Nihon Kohden, Tokyo, Japan). The liquid junction potential between external and internal solutions was measured with a 3 M KCl-agar electrode to calibrate the actual membrane potential. Capacity transients were subtracted on-line by analog compensation in the amplifier. Series resistance compensation was not used routinely. Cell membrane capacitance was calculated after entering the whole-cell configuration, from the integral of the capacity transient elicited by a 10 mV hyperpolarizing pulse from Ϫ60 mV. Peak amplitude of Ca 2ϩ current was divided by the cell membrane capacitance value to obtain Ca 2ϩ current density. Cells were held at Ϫ60 mV, and the membrane potential was stepped every 15 sec through a 1.75 sec prepulse to Ϫ100 mV, followed by a 250 msec depolarizing test pulse to a potential between Ϫ60 mV and ϩ60 mV. Recorded currents were filtered at 5 kHz, monitored on an oscilloscope and a pen recorder, and stored at 20 kHz on a digital audiotape recorder RD-125T (TEAC, Tokyo, Japan) for later off-line analysis using an analysis program (QP-120J, Nihon Kohden) on a personal computer. All experiments were performed at room temperature (20 -25ЊC).
STBodipy-DHP binding. Binding of STBodipy-DHP to hippocampal neurons was examined according to the methods described previously (Knaus et al., 1992) . The cultured cells on coverslips were incubated for 5 min in the dark at room temperature with 10 nM STBodipy-DHP in BSS. After incubation, the cells were rapidly washed twice for 30 sec with ice-cold BSS containing 1% bovine serum albumin, and they were rinsed additionally with ice-cold BSS. The coverslip then was immediately mounted on the stage of a confocal laser microscope for observation of the fluorescence.
Confocal microscopy. Confocal imaging was carried out with a laser scanning confocal system MRC-600 (BioRad, Hercules, CA) equipped with an inverted microscope (Nikon), an argon ion laser, and a host computer system integrated with an optical disk for image storage. All image generation and processing operations were performed by software provided with the confocal system. For the measurements of STBodipy-DHP and fluo-3 fluorescence, the cells were illuminated with the excitation wavelengths of 514 nm and 488 nm, and the fluorescence images were obtained through 550 nm and 515 nm long-pass filters, respectively. The cells were viewed first with a 20 ϫ 0.5 NA objective using a phase-contrast condenser to search a field to be tested, and then with a 60 ϫ 1.4 NA oil immersion objective to obtain fluorescence images. The images of STBodipy-DHP fluorescence were composed of whole hori-zontal sections of hippocampal neurons at 1 m intervals (ϳ20 images), and the changes in the intensity of fluo-3 fluorescence caused by the 50 mM K ϩ challenge were taken from look-through projection, with the spatial filter aperture fully opened. To make quantitative measurements, the same neutral density filter and level of photomultiplier output were used for all images in the same set of experiments. In the experiments using STBodipy-DHP, all images were taken within 10 min after incubation. Under these experimental conditions, the fluorescence of each dye was stable, and photobleaching could be reduced to a minimum. To quantify the intensity of STBodipy-DHP fluorescence on the cell body, the pixel intensity values (0 -275) obtained by maximum pixel mode were averaged for each cell within the image of the somatic region. The vertical position of the maximal value at each pixel apparently followed that of plasma membrane, indicating that STBodipy-DHP fluorescence was associated primarily with plasma membrane, not internal membranes. Changes in the intensity of fluo-3 fluorescence were also expressed by maximum pixel values between 0 and 275.
Evaluation of neurite branching. Evaluation of neurite branching was performed according to the methods described previously (Aoyagi et al., 1994) , with some modifications. Briefly, we selected neurons with neurites longer than their soma diameters at 2 DIV, which were free from contact with other cells, and recorded their locations in the culture dish using an ACAS 470 work station (Meridian, Okemos, MI). These cells were photographed and then drugs were added to the cultures. The same cells were again photographed 48 hr later (at 4 DIV). The number of branch points along the longest neurite was counted by tracing the photographs on a digitizing tablet. If the selected neurons died within 48 hr, data from these cells were discarded. Neurons with many neuritic spine-like protrusions were frequently encountered in bFGF-treated cultures. Neuriteneurite branches are differentiated from neurite-spine branches according to the length of their collaterals (Yu et al., 1994; Papa et al., 1995) . We defined the branches with collateral Ͼ20 m as neurite-neurite branches.
Statistics. Data are presented as mean Ϯ SEM. Statistical significance was evaluated with either Student's t test or one-way ANOVA followed by Duncan's multiple-range test.
Drugs and chemicals. The bFGF used in the present study is CS23 (a generous gift from Takeda Chemical Industries, Osaka, Japan), a modified human bFGF in which serine is substituted for cysteine at amino acid residues 70 and 88 to prevent conformational changes and increase stability. The biological activity of CS23 on brain neurons is virtually the same as that of wild-type human bFGF and bovine bFGF (Abe et al., 1990) . Nicardipine was a generous gift from Yamanouchi Pharmaceutical (Tsukuba, Japan). Thapsigargin was purchased from Research Biochemicals (Natick, MA). All other chemicals were purchased from Wako Chemicals (Osaka, Japan), unless specified otherwise. (Fig.  1 A) . Although the cells are not morphologically differentiated at this developmental stage, most of them are probably neurons because the presence of glial cells in fresh cultures is minimal (Banker and Cowan, 1977) . Hippocampal neurons extended neurites as the culture period proceeded, and both the amplitude of the high K ϩ -induced Ca 2ϩ transients and the percentage of cells responding to high K ϩ gradually increased, which indicates that they had undergone neuronal differentiation ( Fig. 1 A, B , Table 1 ). In the bFGF-treated cultures, neuritic complexity was increased (see below), and the developmental increase in the amplitude of Ca 2ϩ transients was enhanced ( Fig. 1 A, B) . When 10 ng/ml bFGF was added to the culture medium at 0.5 DIV, the amplitude of Ca 2ϩ transients measured at 2 DIV was increased significantly, and this increased Ca 2ϩ response in bFGF-treated cultures was maintained to 4 DIV ( Fig. 1 B, solid circles) . Moreover, bFGF was also effective when added to the medium from 2 DIV (Fig. 1 B,  solid squares) , and the amplitude of the Ca 2ϩ transients caused by high K ϩ was significantly increased even when measured 24 hr later (at 3 DIV). On the other hand, the developmental increase in the percentage of cells responding to high K ϩ depolarization was not affected by the chronic treatment with bFGF ( Table 1 ). The effects of varying concentrations of bFGF were also examined on the development of intracellular Ca 2ϩ responses. As shown in Figure 1C , bFGF increased the amplitude of high K ϩ -induced Ca 2ϩ transients in a concentration-dependent manner, within a range of 1-30 ng/ml.
RESULTS bFGF enhances developmental increases in high K
To confirm that the observed Ca 2ϩ responses to high K ϩ depolarization were mediated by Ca 2ϩ influx through VDCCs, we tested the effect of Cd 2ϩ , a broad-spectrum VDCC blocker. Ca 2ϩ transients were elicited repeatedly in the same neurons by the application of high K ϩ solution at 12 min intervals, and 20 M Cd 2ϩ was applied 6 min before the second challenge with high K ϩ . In both control and bFGF-treated neurons, Cd 2ϩ markedly reduced the amplitudes of Ca 2ϩ transients caused by the second challenge with high K ϩ , compared with those caused by the first challenge (Fig. 1 D) . Ca 2ϩ response to later high K ϩ challenge after washout of Cd 2ϩ showed a tendency to recover (data not shown). To clarify further the subclasses of VDCCs responsible for the high K ϩ -induced Ca 2ϩ transients, we examined the effects of the selective VDCC blockers nicardipine (an L-type VDCC blocker) and -CTx (an N-type VDCC blocker). In both control and bFGF-treated neurons, 10 M nicardipine almost completely abolished the Ca 2ϩ transients caused by high K ϩ ; the amplitude of [Ca 2ϩ ] i rise in the presence of nicardipine fell to ϳ5% of that elicited by the first high K ϩ challenge (Fig. 1 D) . On the other hand, -CTx had no significant effect on the high K ϩ -induced Ca 2ϩ response, although a small decrease (ϳ13%) in the amplitude was noted in bFGF-treated neurons. These results show that depolarization-induced Ca 2ϩ responses in our hippocampal cultures are initiated by the opening of L-type VDCCs. stores (Tsien and Tsien, 1990; Miller, 1991) before the challenge with high K ϩ solution. Application of 50 mM caffeine for 15 sec caused small elevations of [Ca 2ϩ ] i in both control (18 of 49 neurons tested) and bFGF-treated (7 of 29 neurons tested) cultures. No significant differences were observed between control ] i rise in response to 50 mM K ϩ versus the numbers of cells examined. Percentages of responding cells are given in parentheses. bFGF was added to cultures at 0.5 DIV.
Ca
and bFGF-treated neurons in the amplitude of Ca 2ϩ transients elicited by caffeine (Fig. 2 A, open columns) and in the percentage of responding cells. Subsequent challenge with high K ϩ solution caused much larger Ca 2ϩ transients in both control and bFGFtreated neurons compared with that induced by caffeine. As shown in Figure 2 A (hatched columns) , the amplitude of the Ca 2ϩ transients caused by high K ϩ was significantly larger in bFGFtreated neurons compared with that in control neurons, even after the releasable Ca 2ϩ was depleted from intracellular stores by caffeine.
Second, we used another compound, thapsigargin, which depletes intracellular Ca 2ϩ stores by inhibition of the endoplasmic reticulum Ca 2ϩ -ATPase (Thastrup et al., 1990) . Most of the hippocampal neurons did not respond to a 3 min perfusion of 1 M thapsigargin; a small sustained elevation of basal [Ca 2ϩ ] i was observed in a minor population (45 Ϯ 21 nM in control, 10 of 36 neurons tested; 27 Ϯ 4 nM in bFGF-treated, 4 of 39 neurons tested). After the treatment with thapsigargin, the amplitude of Ca 2ϩ transients elicited by high K ϩ was reduced slightly in both control and bFGF-treated neurons. The degree of reduction, however, was almost the same in both groups (by ϳ20%). The amplitude of depolarization-induced Ca 2ϩ transients was still significantly larger in bFGF-treated neurons compared with control (Fig. 2 B) . Because the concentrations of caffeine and thapsigargin that were used were reported to be sufficient for depleting internal Ca 2ϩ stores in a number of studies (Verkhratsky and Shmigol, 1996) , we suggest that the development of the intracellular Ca 2ϩ stores was poor in hippocampal neurons under the present experimental conditions, and the contribution of the intracellular Ca 2ϩ stores to depolarization-induced Ca 2ϩ transients was relatively small. Thus, we conclude that the enhanced Ca 2ϩ responses in bFGF-treated neurons are attributable not to an increased amplification by Ca 2ϩ -induced Ca 2ϩ release but to an increased Ca 2ϩ influx through VDCCs.
Involvement of protein synthesis in bFGF action
bFGF is known to activate its specific receptor tyrosine kinases and also to activate other protein kinases as a cascade of intracellular events (Jaye et al., 1992; Creuzet et al., 1995) . Therefore, the observed effect of bFGF may be mediated by phosphorylation of Ca 2ϩ channel proteins by these protein kinases, because VDCC functions can be modulated by phosphorylation (Dolphin, 1996) . If so, bFGF also should be effective when applied acutely, because phosphorylation-based modulation of ion channel activities is expected to manifest quickly. Acute application of bFGF (20 ng/ml), however, did not enhance but rather slightly depressed the amplitude of Ca 2ϩ transients caused by high K ϩ depolarization (Fig. 3A, B) . We also tested the effect of a 1 hr incubation of hippocampal neurons with 10 ng/ml bFGF just before the [Ca 2ϩ ] i measurement. bFGF again failed to enhance high K ϩ -induced Ca 2ϩ response (data not shown). These results suggest, although indirectly, that phosphorylation of Ca 2ϩ channel proteins is not likely to be the mechanism of bFGF action.
Another possible mechanism is that bFGF may increase the amount of Ca 2ϩ channel proteins themselves on the plasma membrane. In other words, the effect of bFGF may be mediated by enhancement of new protein synthesis. To test this possibility, hippocampal neurons were incubated with the protein synthesis inhibitor cycloheximide (0.1 M) or the RNA synthesis inhibitor actinomycin D (1 nM) during the bFGF treatment from 2 to 4 DIV. These inhibitors did not produce any cell damage at the concentrations used. As shown in Figure 3C ,D, both cycloheximide and actinomycin D virtually abolished bFGF-stimulated increase in Ca 2ϩ response. These results suggest that neosynthesis of proteins and RNAs is required for this effect of bFGF.
Whole-cell Ca 2؉ current is enhanced by bFGF treatment
To assess more directly whether the amount of VDCCs is increased in bFGF-treated cultures, we measured voltage-activated Ca 2ϩ currents (I Ca ) using whole-cell patch-clamp recording techniques. Membrane potentials of hippocampal neurons grown in the absence and presence of bFGF (10 ng/ml) from 0.5 to 4 DIV were held at Ϫ60 mV, and whole-cell I Ca was evoked by step depolarization over the range of Ϫ60 to ϩ60 mV from the membrane potential prepulsed to Ϫ100 mV. In both control and bFGF-treated neurons, low-voltage-activated I Ca , which was activated at relatively low membrane potential (Ϫ50 to Ϫ40 mV), and high-voltage-activated I Ca , which was activated at relatively high membrane potential (Ϫ30 to Ϫ20 mV), were observed, in good agreement with previous reports (Yaari et al., 1987; Ozawa et al., 1989) . bFGF (10 ng/ml) treatment significantly increased highvoltage-activated I Ca (Ϫ10 to ϩ20 mV). Representative current traces evoked by depolarization to 0 mV were shown in Figure  4 A. The peak I Ca measured at 0 mV test potential was 693 Ϯ 55 pA (n ϭ 5) in control and 1109 Ϯ 119 pA (n ϭ 6) in bFGF-treated neurons (Fig. 4 B) . On the other hand, low-voltage-activated I Ca activated at Ϫ50 to Ϫ40 mV remained unchanged (Fig. 4 B) . We also evaluated the amplitude of low-voltage-activated transient I Ca by subtracting the sustained current amplitude remaining at the end of the voltage step from the peak current amplitude, and again observed no significant difference between control and bFGF-treated neurons (data not shown). These results indicate that bFGF treatment specifically increased high-voltage-activated I Ca .
The enhancement of I Ca under bFGF treatment could be the consequences of an increase in specific ion conductance or an enlargement of membrane surface. Thus, we also measured cell membrane capacitance as an indicator of the size of the neurons and calculated the I Ca density at 0 mV test potential. The I Ca density increased with the length of the culture period, and bFGF significantly enhanced the developmental increase in the I Ca density (Fig. 4C) . On the other hand, no significant difference in the cell membrane capacitance was found between control and bFGFtreated neurons (at 4 DIV, 35.8 Ϯ 2.2 pF in control, n ϭ 5 vs 37.7 Ϯ 3.8 pF in bFGF-treated, n ϭ 6). bFGF affected the I Ca density in a concentration-dependent manner (Fig. 4C) . Moreover, I Ca measurement was performed on the neurons that received 0.1 M cycloheximide during bFGF treatment. Cyclohexi- mide prevented enhancement of the I Ca density increase by bFGF (Fig. 4 B,C) , which was consistent with the results obtained from [Ca 2ϩ ] i measurement experiments (Fig. 3C) . These results suggest that the bFGF-stimulated increase in I Ca is attributable to an increase in the density of functional VDCCs on the plasma membrane.
Increased expression of L-type Ca
2؉ channels on the soma under bFGF treatment Next we performed another set of experiments to verify increased expression of VDCCs in bFGF-treated neurons. Here the expression of L-type VDCCs was quantified by the binding of STBodipy-DHP to living hippocampal neurons. STBodipy-DHP is a useful agent for visualization of L-type VDCCs (Knaus et al., 1992) . Subcellular regions expressing the DHP-receptor domain of L-type VDCCs were visualized clearly by confocal microscopy (Fig. 5A, B) . In control neurons, STBodipy-DHP fluorescence was distributed unevenly on the cell body. Each neuron had a "hot region" where L-type VDCCs were densely expressed (Fig. 5A) .
The intense labeling did not seem to be attributable to the thickness of the cells and cytoplasmic fluorescence, because maximum pixel mode was used to construct the images and no obvious difference was observed in cell thickness between the hot region and the other areas of soma. To check the specificity of STBodipy-DHP binding to L-type VDCCs, displacement experiments were carried out using the VDCC blockers nicardipine and -CTx. In the neurons pretreated with 10 M nicardipine, the hot region was absent (data not shown). The averaged fluorescence intensity on the cell bodies decreased to 54% of control for the neurons pretreated with nicardipine (Fig. 5C ). In contrast, 300 nM -CTx had little effect on the binding of STBodipy-DHP (Fig. 5C) . Thus, STBodipy-DHP recognizes L-type VDCCs in hippocampal neurons.
After 24 hr treatment with 10 ng/ml bFGF from 2 DIV, the capacity of STBodipy-DHP binding on the cell bodies of hippocampal neurons increased significantly, compared with that of nontreated neurons (Fig. 5B) . The averaged fluorescence intensity on the cell bodies increased to 146% of control, whereas the characteristic pattern of the distribution of STBodipy-DHP fluorescence was retained. The hot region increased both in area and in fluorescence intensity. Furthermore, with careful observation we noted that the expression of L-type VDCCs was increased along the neurites (described below). We also examined high K ϩ -induced Ca 2ϩ responses in the same neurons before STBodipy-DHP binding experiments. The intensity of STBodipy-DHP fluorescence and the amplitude of [Ca 2ϩ ] i responses showed a significant correlation (r ϭ 0.31, p Ͻ 0.05; Fig. 5D ). Thus, the enhanced Ca 2ϩ response by bFGF treatment was associated with the increased expression of L-type VDCCs on the cell body.
Distribution of L-type Ca 2؉ channels along neurites
As mentioned above, neuritic complexity was increased and the expression of L-type VDCCs seemed to increase along the neurites of bFGF-treated neurons. Therefore, we further examined the distribution of L-type VDCCs on the neurites based on the observations of STBodipy-DHP fluorescence. For this purpose, we used hippocampal neurons plated at a low density. When plated at 2500 cells/cm 2 , individual neurons extended neurites without any contact with other neighboring neurons. Application of 10 ng/ml bFGF to low-density culture markedly increased the number of branches of the longest neurite of hippocampal neurons (Fig. 6 A-C) . When visualized by STBodipy-DHP fluorescence, mild expression of L-type VDCCs was observed along the neurites of bFGF-treated neurons, whereas in control neurons the expression was weak, present only on the proximal part of neurites (Fig. 6 D-F ) . In addition, we could observe several fluorescent "hotspots," which were assumed to represent clusters of L-type VDCCs, on the distal part of neurites of bFGF-treated neurons. These hotspots were expressed in a punctate appearance, overlapping with either the branch points or varicosities (enlargements on the neurites) along the neurites (Fig. 6H, I, K, L) . No such fluorescent hotspots were observed on the neurites of control neurons (Fig. 6G, J) .
To evaluate the expression of L-type VDCCs on the neurites quantitatively, we selected neurons that had complexly branching neurites in bFGF-treated cultures and size-matched neurons in control cultures. We measured the averaged intensity of STBodipy-DHP fluorescence on the cell body of control neurons and made it a criterion for evaluating the quantity of L-type VDCCs on the longest neurite. The number of pixels that had a fluorescence intensity above the criteria was remarkably increased along the longest neurite of bFGF-treated neu- , bFGF-treated (10 ng/ml) (n ϭ 6, solid squares), and bFGF ϩ cycloheximide-treated (0.1 M) (n ϭ 3, solid triangles) neurons at 4 DIV. Currents were evoked by step depolarization over the range of Ϫ60 to ϩ60 mV from a holding potential of Ϫ100 mV. The peak amplitude of I Ca was measured and plotted against test potential. Note that bFGF treatment significantly increased high-voltageactivated I Ca , whereas low-voltage-activated I Ca remained unchanged. Asterisks indicate significant differences from the control group; *p Ͻ 0.05 (Student's t test). C, Development of I Ca density in the absence (open bars) and presence (hatched bars) of bFGF at indicated concentrations (in ng/ml). Cell membrane capacitance was measured, and the I Ca density at 0 mV test potential was calculated. The I Ca density increased with the length of culture period (0.5 to 4 DIV). bFGF significantly enhanced the developmental increase of the I Ca density. CHX (0.1 M) blocked the enhancement of the I Ca density by bFGF treatment. The number of neurons examined is given in parentheses. Asterisk indicates significant difference from the control group (C); *p Ͻ 0.05 (Duncan's multiple-range test).
rons (Fig. 6 M) . This indicates that bFGF increased the expression of L-type VDCCs on the neurites as well as on the cell body.
Furthermore, to test whether the clusters of L-type VDCCs could result in altered [Ca 2ϩ ] i regulation at the branch points of neurites, we examined the intracellular Ca 2ϩ responses to high K ϩ depolarization at these branch points. The Ca 2ϩ -sensitive dye fluo-3 was used, and Ca 2ϩ responses to high K ϩ -induced depolarization were measured using a confocal laser microscope. As shown in Figure 7 , neurites of bFGF-treated neurons showed large Ca 2ϩ responses compared with neurites of control neurons. Moreover, within the neurites of bFGF-treated neurons, Ca 2ϩ Figure 5 . Visualization of L-type VDCCs on rat hippocampal neurons by STBodipy-DHP. A, B, Pseudo-color confocal images of STBodipy-DHP fluorescence in living hippocampal neurons at 3 DIV, cultured in the absence (A) and presence (B) of 10 ng/ml bFGF for 24 hr. The number of DHP-binding sites shown as fluorescence intensity increased in bFGF-treated neurons. Scale bar, 25 m. C, Competition of the binding of STBodipy-DHP (10 nM) with nicardipine (Nic) (10 M) and -CTx (300 nM). Nicardipine markedly reduced fluorescence intensity, whereas -CTx had no effect. Asterisk indicates significant difference from the control group (c); **p Ͻ 0.01 (Student's t test). D, Correlation of the magnitude of Ca 2ϩ response with the amount of L-type VDCCs. Ca 2ϩ responses to 50 mM K ϩ depolarization were measured by fura-2 microfluorometry. After that, the same cultures were used for STBodipy-DHP binding experiments. The amplitudes of [Ca 2ϩ ] i responses are plotted against the intensities of STBodipy-DHP fluorescence for individual neurons. Open circles, control; solid circles, bFGF-treated (10 ng/ml). Significant correlation between the two parameters was obtained (r ϭ 0.31, p Ͻ 0.05). responses to high K ϩ depolarization were much larger at the branch points compared with adjacent regions not forming branches (Fig. 7B,D,F ) . Therefore, it is suggested that L-type VDCC hotspots function as "Ca 2ϩ hotspots" at the branch points of neurites of bFGF-treated neurons.
Possible involvement of L-type Ca 2؉ channel expression in bFGF-induced neurite branching
Because several studies suggest a close relationship between Ca 2ϩ influx and the establishment of neurite morphology (Neely and Nicolls, 1995) , we inferred that bFGF-promoted neurite branching was relevant to the increased expression of L-type VDCCs along the neurites. This possibility was examined by testing the effects of VDCC blockers on neurite morphogenesis. As shown in Figure 8 A, nicardipine (5 M) alone did not affect the branch formation of the longest neurite of hippocampal neurons, but when added together with bFGF, completely blocked the branching-promoting effect of bFGF (10 ng/ml). Moreover, the density of spine-like protrusions along the neurites was increased in bFGF-treated neurons. Nicardipine also eliminated these bFGF-induced sprouting of spines along the neurites (Fig. 8 B-D) .
DISCUSSION
We have demonstrated in the present study that fetal hippocampal neurons chronically exposed to bFGF acquire increased responsiveness mediated by the opening of L-type VDCCs. This was observed as an increased [Ca 2ϩ ] i response to high K ϩ -induced membrane depolarization. The selective L-type VDCC blocker nicardipine virtually abolished the [Ca 2ϩ ] i response (Fig. 1 D) . Moreover, the results of thapsigargin and caffeine experiments (Fig. 2) suggest that the contribution of Ca 2ϩ -induced Ca 2ϩ release to this response was minimal. Therefore, the depolarization-induced Ca 2ϩ response in our hippocampal primary cultures well represents the activities of L-type VDCCs, which allowed us to estimate the amount of functional Ca 2ϩ channels using [Ca 2ϩ ] i measurement experiments. The most well established separation among various VDCC subclasses is that between the low-voltage-activated and the highvoltage-activated channels Hess, 1990; Swandulla et al., 1991) , L-type VDCC being one of the major highvoltage-activated channels present in hippocampal neurons (Ozawa et al., 1989) . Indeed, whole-cell voltage-clamp recordings demonstrated that high-voltage-activated Ca 2ϩ currents were significantly larger in bFGF-treated neurons than in nontreated neurons (Fig. 4) . A specific enhancement in high-voltageactivated Ca 2ϩ conductance was demonstrated because cell membrane capacitance, which reflected cell size and membrane surface area, was not affected by bFGF treatment. In contrast, lowvoltage-activated Ca 2ϩ currents were not altered by bFGF treatment, which suggests distinct regulation of these two major Ca 2ϩ channel types.
The increased Ca 2ϩ channel responses could be a consequence of covalent modification of Ca 2ϩ channel proteins themselves by protein phosphorylation. Voltage-dependent Ca 2ϩ currents can be facilitated by phosphorylation (Dolphin, 1996) . Furthermore, bFGF mediates its effects through specific high-affinity receptors that contain a tyrosine kinase activity and initiates a cascade of intracellular events that leads to the activation of other protein kinases (Jaye et al., 1992; Creuzet et al., 1995) . Indeed, Ca 2ϩ currents in several cell types, including retinal glial cells (Puro and Mano, 1991) and subpopulations of ventromedial hypothalamic neurons (Koike et al., 1993) , are enhanced by acute treatment with bFGF, which may be mediated by channel protein phosphorylation; however, this does not seem to be the case with hippocampal primary cultures in the present study. Rather, it is concluded for the following reasons that the increased Ca 2ϩ responses are attributable to the increased expression of functional L-type Ca 2ϩ channel proteins on the plasma membrane. First, the effects of bFGF required chronic exposure of hippocampal neurons: acute treatment with bFGF had no effect on high K ϩ -induced Ca 2ϩ response. Second, cycloheximide and actinomycin D completely blocked the bFGF-stimulated increase in high K ϩ -induced Ca 2ϩ response and high-voltage-activated Ca 2ϩ currents, indicating that new protein synthesis is required for these effects. Third, increased Ca 2ϩ responses were accompanied by the increased capacity of STBodipy-DHP binding on bFGFtreated neurons.
VDCCs are composed of distinct classes of interacting subunits: ␣ 1 , ␣ 2 /␦, ␤, and ␥ (Dunlap et al., 1995) . Of these, the ␣ 1 subunit plays a major role in the sense that it forms a channel pore, can function as a Ca 2ϩ channel by itself, and represents basic characteristics of Ca 2ϩ channel subclasses. ␣ 1C and ␣ 1D subunits represent brain L-type Ca 2ϩ channels, both of which possess a DHPbinding domain. STBodipy-DHP is a fluorescent DHP analog that recognizes this DHP-binding domain (Knaus et al., 1992) . Therefore, the increased capacity of STBodipy-DHP binding reflects an increase in the amount of ␣ 1C and/or ␣ 1D subunit proteins on the cell membrane. This increase can be accomplished by several mechanisms. That is, the increase in the amount of channel proteins may be exerted directly by increased expression of genes encoding ␣ 1C and/or ␣ 1D subunit proteins. Alternatively, changes in the expression of the other subunit proteins may affect the amount of functional VDCCs expressed on the plasma membrane. For example, a recent report showed that ␤ 2a subunit co-transfected with ␣ 1C subunit in human embryonic kidney cells markedly increased the membrane localization of ␣ 1C subunit proteins (Chien et al., 1995) . Degradation rate can also determine the amount of channel proteins; the increased expression of nicotinic receptors in muscle fibers is caused not only by increased protein synthesis (Devreotes and Fambrough, 1975) but also by a decrease in the rate of receptor protein degradation (Shyng et al., 1991) . These alternatives should be addressed in future studies by measuring the amount of Ca 2ϩ channel subunit mRNAs. It should be noted that the activation of FGF receptors can lead to genomic alterations through the induction of immediate early genes (Altin et al., 1991; Ferhat et al., 1993) . Some of the proteins encoded by these genes act as transcription factors regulating the expression of other genes involved in cellular growth and differentiation (Sheng and Greenberg, 1990) . There is also evidence that immediate early genes c-fos and c-jun can upregulate membrane Ca 2ϩ conductance in a rat pheochromocytoma cell line (Cavalie et al., 1994) .
The initial fura-2 Ca 2ϩ imaging experiments were concerned with somatic Ca 2ϩ responses. The results of whole-cell recording experiments also provided information mainly about somatic Ca 2ϩ channels, and may not reflect the properties of dendritic Ca 2ϩ channels caused by space-clamp problems. On the other hand, confocal image analysis of STBodipy-DHP binding revealed specialized distribution of L-type VDCCs on the cell bodies as well as on neurites of hippocampal neurons. Each neuron had a hot region on the cell body. Such distribu-tion is similar to that observed in hippocampal neurons in vivo. Clustering of L-type VDCCs is usually observed in the somatic region from which the major dendrite originates (Westenbroek et al., 1990) . bFGF enhanced the expression of L-type VDCCs without disturbing this distribution pattern within the cell body (Fig. 5B) . Furthermore, bFGF treatment induced characteristic distribution of L-type VDCCs at the branching points of neurites (Fig. 6 ). These branch points showed large [Ca 2ϩ ] i increases in response to high K ϩ -induced membrane depolarization, as revealed by fluo-3 confocal imaging (Fig. 7) . These findings are particularly intriguing because one of the most prominent effects of bFGF on fetal hippocampal neurons is an increase in the number of axonal branches (Miyagawa et al., 1993; Aoyagi et al., 1994) . Consistent with previous studies, we observed a marked increase in the number of branching points along the neurites of bFGF-treated neurons (Figs. 6, 8) .
The mechanisms by which neuritic branching is formed are not yet clear, but several lines of evidence suggest that Ca 2ϩ plays an important role (Yu et al., 1994; Neely and Nicolls, 1995) . Manivannan and Terakawa (1994) reported that depolarizing current injection into varicosities induced rapid sprouting of filopodia in a Ca 2ϩ -dependent manner. We propose here that bFGF promotes the formation of clusters of L-type VDCCs along the neurites, and these clusters serve as Ca 2ϩ hotspots. Evidence has suggested that the cluster of Ca 2ϩ channels can mediate [Ca 2ϩ ] i rise enough to activate many kinds of Ca 2ϩ -dependent biochemical processes in that region (Silver et al., 1990) . Therefore, Ca 2ϩ increase at the hotspots could cause cytoskeletal rearrangement (Yu et al., 1994; Neely and Nicolls, 1995) , which leads to the formation of neuritic branching (Aoyagi et al., 1995) . Indeed, we have found in the present study that nicardipine completely blocks the increase in neuritic branching induced by bFGF (Fig. 8) , indicating that a bFGF-induced increase in L-type VDCC activities and an increase in neuritic branching are closely associated events.
Regulation of neuronal Ca 2ϩ channels is important because entry of Ca 2ϩ through VDCCs is a major mechanism by which changes in membrane potential can influence cellular processes. Enhanced Ca 2ϩ influx resulting from an increased density of Ca 2ϩ channels could modulate Ca 2ϩ -dependent factors leading to changes in neuronal excitability. Experimental evidence supports this view that Ca 2ϩ is an important intracellular regulator of neuronal excitability in the hippocampus (Kennedy, 1989) . In addition to being a determinant of the electrophysiological characteristics of many cells, voltageactivated Ca 2ϩ influx can trigger cellular events such as the activation of enzymes, which in some cases leads to genomic responses (Ghosh and Greenberg, 1995) . Indeed, vigorous elevation of Ca 2ϩ can influence differentiation and growth of neuronal cells (Spitzer, 1994) .
bFGF has been implicated in differentiation and survival of neuronal cells of various brain regions (Ray et al., 1993; Baird, 1994; Vicario-Abejon et al., 1995) . From the point of view that Ca 2ϩ is a critical signal in neuronal development, we propose that the enhanced expression of L-type VDCCs should play a particularly important role in cell growth and differentiation regulated by bFGF. 
